This lecture will provide an overview of the burden and outcomes of COVID-19 among patients living with cance
|
Genitourinary malignancies will account for approximately 20% of newly diagnosed cancers in 2021.
|
Immune Thrombocytopenic Purpura and Thrombotic Thrombocytopenic Purpura are both autoimmune conditions leadin
|
This is a case-based lecture to cover the common side effects and rare but important side effects of check point inhibitors and other immunotherapy agents.
|
This talk aims to provide a general background on the breadth and application of genetic testing in cancer patients.
|
Drs. Stephanie Wheeler and Don Rosenstein will discuss current concepts related to “financial toxicity” and how this applies to cancer care delivery in North Carolina.
|
Dr. Hyman Muss will discuss recommendations related to specific needs of older patients with cancer.
|
Terri Phoenix, PhD, and Patricia Morfeld, RN, BSN, OCN, will discuss physical and psychological concerns of transgender patients who have active cancer or who are survivors.
|
Dr. Michelle Gardiner will discuss topics relevant to common and problematic side effects of anti-cancer treatments.
|
CAR-T therapy is expanding as a therapeutic option both in clinical trials and FDA approved commercial produc
|